Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?
Journal of General Physiology · 03.04.2023 · 155 (4)
DOI: 10.1085/jgp.202313351 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of General Physiology, online erschienen am 22.03.2023. Verfasst von David Y Barefield. Beteiligte Einrichtung: Department of Cell and Molecular Physiology, Loyola University Chicago , Maywood, IL, USA. Hauptthemen laut MEDLINE: Cardiomyopathy, Hypertrophic, Carrier Proteins. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0). Gefördert von: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Reduced expression of MYBPC3 causes early dysfunction in human cell culture models prior to reduced cMyBP-C levels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Cell and Molecular Physiology, Loyola University Chicago , Maywood, IL, USA.
ORCID-Profile: David Y Barefield
Förderung
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Barefield, D. Y. (2023). Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?. Journal of General Physiology, 155(4). https://doi.org/10.1085/jgp.202313351
Vancouver
Barefield DY. Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?. Journal of General Physiology. 2023;155(4). doi:10.1085/jgp.202313351
BibTeX
@article{Barefield2023,
author = {Barefield, David Y},
title = {Is haploinsufficiency a sufficient mechanism for MYBPC3 truncating mutations?},
journal = {Journal of General Physiology},
year = {2023},
volume = {155},
number = {4},
doi = {10.1085/jgp.202313351}
}
EUVIMED